Search Ontology:
ChEBI
alogliptin
- Term ID
- CHEBI:72323
- Synonyms
-
- 2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile
- alogliptin
- alogliptina
- alogliptine
- alogliptinum
- Definition
- A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes.
- References
-
- CAS:850649-61-5
- Drug_Central:4340
- PMID:20040339
- PMID:21205126
- PMID:21397040
- PMID:21431099
- PMID:21558879
- PMID:21595274
- PMID:21595275
- PMID:21682833
- PMID:21733058
- PMID:21806314
- PMID:22106975
- PMID:22162539
- PMID:22237690
- PMID:22249941
- PMID:22296609
- PMID:22419732
- PMID:22429011
- PMID:22512582
- PMID:22583697
- PMID:22651127
- PMID:22832924
- PMID:23220949
- PMID:23289982
- PMID:23298374
- Patent:EP1970063
- Patent:US2007066635
- Patent:US2009275750
- Patent:WO2008028914
- Patent:WO2009022009
- Patent:WO2010072680
- Reaxys:10587993
- Wikipedia:Alogliptin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from alogliptin
Phenotype where environments contain alogliptin
Phenotype modified by environments containing alogliptin
Human Disease Model